Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small ...

An investigational PCSK9 inhibitor with a different mechanism from existing drugs in this class has been shown to safely and ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Biomay today announced to offer GMP services for lipid-based nanoparticles (LNPs). With this, the company has completed its end-to-end platform for manufacturing of GMP-grade mRNA drugs from scratch.

Researchers have uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics, which could pave the way for more effective RNA-based therapies.

Unlike animals, plants do not possess an adaptive immune system with antibodies or T cells to fight viral infections. Instead, they rely on the RNA silencing system, which serves as their innate ...

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, necessitating new therapeutic strategies. CDK4/6 inhibitors show promise ...

The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting hepatic synthesis of lipoprotein(a), are unknown. We randomly assigned participants in a 1:2:2:2:2 ...